| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $76M | ||
| $62M |
Buys | $0 | 0 | 0 |
Sells | $375,862 | 12 | 100 |
| Dmytruk Mark E. | See remarks | 0 | $0 | 2 | $14,415 | $-14,415 |
| Coen Steven P. | See remarks | 0 | $0 | 8 | $141,647 | $-141,647 |
| HENRY CHRISTIAN O | director | 0 | $0 | 2 | $219,800 | $-219,800 |
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Over the last 12 months, insiders at Ginkgo Bioworks Holdings, Inc. have bought $0 and sold $375,862 worth of Ginkgo Bioworks Holdings, Inc. stock.
On average, over the past 5 years, insiders at Ginkgo Bioworks Holdings, Inc. have bought $873,283 and sold $40.72M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 625,000 shares for transaction amount of $514,750 was made by Sankar Shyam (director) on 2024‑05‑15.
| 2026-01-20 | Sale | Coen Steven P. | See remarks | 972 0.0017% | $8.92 | $8,667 | +6.71% | |
| 2025-12-15 | Sale | Coen Steven P. | See remarks | 736 0.0014% | $8.89 | $6,540 | +4.47% | |
| 2025-10-17 | Sale | Coen Steven P. | See remarks | 1,312 0.0024% | $13.65 | $17,907 | -31.21% | |
| 2025-10-01 | Sale | Coen Steven P. | See remarks | 5,609 0.0097% | $15.00 | $84,135 | -36.95% | |
| 2025-09-09 | Sale | HENRY CHRISTIAN O | director | 10,000 0.0174% | $11.06 | $110,600 | -12.69% | |
| 2025-09-08 | Sale | HENRY CHRISTIAN O | director | 10,000 0.0165% | $10.92 | $109,200 | -16.00% | |
| 2025-08-22 | Sale | Coen Steven P. | See remarks | 310 0.0005% | $12.40 | $3,843 | -24.30% | |
| 2025-07-17 | Sale | Coen Steven P. | See remarks | 1,084 0.0019% | $9.84 | $10,669 | +5.23% | |
| 2025-05-21 | Sale | Dmytruk Mark E. | See remarks | 706 0.0012% | $7.58 | $5,355 | +31.89% | |
| 2025-05-21 | Sale | Coen Steven P. | See remarks | 346 0.0006% | $7.58 | $2,624 | +31.89% | |
| 2025-04-21 | Sale | Dmytruk Mark E. | See remarks | 1,244 0.0024% | $7.28 | $9,060 | +28.75% | |
| 2025-04-21 | Sale | Coen Steven P. | See remarks | 997 0.002% | $7.28 | $7,261 | +28.75% | |
| 2025-03-04 | Sale | Dmytruk Mark E. | See remarks | 790 0.0013% | $7.72 | $6,103 | +13.79% | |
| 2025-03-04 | Sale | Coen Steven P. | See remarks | 395 0.0006% | $7.72 | $3,051 | +13.79% | |
| 2025-02-04 | Sale | Dmytruk Mark E. | See remarks | 740 0.0013% | $13.44 | $9,948 | -34.71% | |
| 2025-02-04 | Sale | Coen Steven P. | See remarks | 367 0.0007% | $13.44 | $4,934 | -34.71% | |
| 2025-01-06 | Sale | Dmytruk Mark E. | See remarks | 645 0.0011% | $11.72 | $7,558 | -17.77% | |
| 2025-01-06 | Sale | Coen Steven P. | See remarks | 324 0.0006% | $11.72 | $3,797 | -17.77% | |
| 2024-12-04 | Sale | Dmytruk Mark E. | See remarks | 741 0.0012% | $9.64 | $7,146 | -3.51% | |
| 2024-12-04 | Sale | Coen Steven P. | See remarks | 330 0.0005% | $9.64 | $3,183 | -3.51% |
| Dmytruk Mark E. | See remarks | 46226 0.0763% | $316,185.84 | 0 | 35 | |
| HENRY CHRISTIAN O | director | 24310 0.0401% | $166,280.40 | 0 | 16 | |
| Coen Steven P. | See remarks | 8321 0.0137% | $56,915.64 | 0 | 19 | |
| Shetty Reshma P. | See remarks | 12374544 20.4233% | $84.64M | 0 | 164 | |
| Canton Barry | 10 percent owner | 12374544 20.4233% | $84.64M | 0 | 164 | |
| DEKKERS MARIJN E | director | 5515364 9.1027% | $37.73M | 0 | 3 | |
| Kelly Jason R | See remarks | 3894680 6.4279% | $26.64M | 0 | 166 | |
| Sankar Shyam | director | 2356874 3.8899% | $16.12M | 2 | 0 | <0.0001% |
| SLOAN HARRY | director | 718540 1.1859% | $4.91M | 2 | 0 | <0.0001% |
| Fallon Marie E. | See remarks | 183010 0.302% | $1.25M | 0 | 9 | |
| LEVINSON ARTHUR D | CHAIRMAN & CEO | 9268 0.0153% | $63,393.12 | 0 | 25 | |
| EBERSMAN DAVID A | EVP & CHIEF FINANCIAL OFFICER | 8097 0.0134% | $55,383.48 | 0 | 7 | |
| SANDERS CHARLES A | director | 2000 0.0033% | $13,680.00 | 0 | 2 | |
| GARNICK ROBERT L | SENIOR VICE PRESIDENT | 1710 0.0028% | $11,696.40 | 0 | 9 | |
| Tessier-Lavigne Marc | EVP, RESEARCH DRUG DISCOVERY | 1159 0.0019% | $7,927.56 | 0 | 1 | |
| CLARK IAN T | EVP-COMMERCIAL | 668 0.0011% | $4,569.12 | 0 | 11 | |
| LAVIGNE LOUIS J JR | EVP AND CFO | 0 0% | $0 | 0 | 7 | |
| RICHMOND MARK SIR | director | 0 0% | $0 | 0 | 6 | |
| SCHELLER RICHARD H | EVP-RESEARCH | 0 0% | $0 | 0 | 40 |
$5,911,307 | 70 | -1.38% | $372.31M | |
$54,836,085 | 68 | -0.52% | $421.5M | |
$17,468,215 | 46 | 18.85% | $395.27M | |
$130,095 | 43 | 45.19% | $441.12M | |
$22,017,898 | 24 | 39.19% | $437.58M | |
$81,667,942 | 12 | -57.54% | $389.46M | |
$92,357,691 | 12 | 87.24% | $435.86M | |
$112,952,085 | 11 | -19.19% | $370.69M | |
$19,167,169 | 10 | 28.48% | $441.55M | |
$603,645 | 8 | 57.40% | $379.31M | |
$91,549,696 | 8 | -6.55% | $398.47M | |
$43,326,461 | 6 | 16.01% | $378.46M | |
$88,549,962 | 5 | -16.91% | $440.71M | |
$79,246,559 | 5 | -27.73% | $437.08M | |
$4,745,999 | 5 | -4.91% | $439.55M | |
$12,035,408 | 5 | -37.54% | $372.89M | |
Ginkgo Bioworks Holdings, Inc. (DNA) | $1,746,565 | 4 | -29.05% | $414.44M |
$184,294 | 3 | -10.64% | $414.07M | |
$3,850,000 | 1 | -51.32% | $441.43M |
| Increased Positions | 85 | +43.81% | 5M | +15.54% |
| Decreased Positions | 70 | -36.08% | 2M | -7.93% |
| New Positions | 33 | New | 2M | New |
| Sold Out Positions | 30 | Sold Out | 287,356 | Sold Out |
| Total Postitions | 209 | +7.73% | 33M | +7.61% |
| Viking Global Investors Lp | $31,121.00 | 7.3% | 3.58M | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $29,737.00 | 6.98% | 3.42M | +367,800 | +12.06% | 2025-09-30 |
| Baillie Gifford & Co | $28,147.00 | 6.6% | 3.24M | -40,797 | -1.25% | 2025-09-30 |
| Vanguard Group Inc | $21,580.00 | 5.06% | 2.48M | +99,379 | +4.17% | 2025-09-30 |
| Erste Asset Management Gmbh | $19,140.00 | 4.49% | 2.2M | +200,000 | +10% | 2025-09-30 |
| Anchorage Capital Group, L.L.C. | $15,193.00 | 3.56% | 1.75M | 0 | 0% | 2025-09-30 |
| Legal & General Group Plc | $13,998.00 | 3.28% | 1.61M | +118,402 | +7.94% | 2025-09-30 |
| Bank Of America Corp /De/ | $9,297.00 | 2.18% | 1.07M | -138,572 | -11.48% | 2025-09-30 |
| Forbes J M & Co Llp | $9,225.00 | 2.16% | 1.06M | -16,900 | -1.57% | 2025-09-30 |
| State Street Corp | $8,124.00 | 1.91% | 933,840 | +192,788 | +26.02% | 2025-09-30 |